Genesis Healthcare Inc (GEN) COO Sells $13,848.00 in Stock

Genesis Healthcare Inc (NYSE:GEN) COO Paul David Bach sold 11,540 shares of the firm’s stock in a transaction dated Monday, May 20th. The shares were sold at an average price of $1.20, for a total value of $13,848.00. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Genesis Healthcare stock traded up $0.03 during midday trading on Thursday, reaching $1.26. The company’s stock had a trading volume of 312 shares, compared to its average volume of 195,187. Genesis Healthcare Inc has a 52-week low of $1.10 and a 52-week high of $2.86. The stock has a market cap of $198.99 million, a PE ratio of -0.81 and a beta of 0.98.

Genesis Healthcare (NYSE:GEN) last released its quarterly earnings results on Thursday, May 9th. The company reported ($0.15) EPS for the quarter, beating analysts’ consensus estimates of ($0.25) by $0.10. The business had revenue of $1.16 billion during the quarter, compared to analysts’ expectations of $1.17 billion. Equities research analysts predict that Genesis Healthcare Inc will post -0.78 EPS for the current fiscal year.

Large investors have recently made changes to their positions in the company. Citigroup Inc. raised its stake in shares of Genesis Healthcare by 74.3% in the fourth quarter. Citigroup Inc. now owns 34,936 shares of the company’s stock worth $41,000 after purchasing an additional 14,893 shares during the last quarter. BlackRock Inc. raised its stake in shares of Genesis Healthcare by 0.7% in the fourth quarter. BlackRock Inc. now owns 3,250,648 shares of the company’s stock worth $3,835,000 after purchasing an additional 24,163 shares during the last quarter. California Public Employees Retirement System raised its stake in shares of Genesis Healthcare by 8.4% in the fourth quarter. California Public Employees Retirement System now owns 383,258 shares of the company’s stock worth $452,000 after purchasing an additional 29,807 shares during the last quarter. Acadian Asset Management LLC raised its stake in shares of Genesis Healthcare by 14.7% in the fourth quarter. Acadian Asset Management LLC now owns 1,691,866 shares of the company’s stock worth $1,996,000 after purchasing an additional 217,438 shares during the last quarter. Finally, Millennium Management LLC raised its stake in shares of Genesis Healthcare by 79.5% in the fourth quarter. Millennium Management LLC now owns 535,970 shares of the company’s stock worth $632,000 after purchasing an additional 237,370 shares during the last quarter. Hedge funds and other institutional investors own 21.31% of the company’s stock.

Separately, Credit Suisse Group reiterated a “hold” rating on shares of Genesis Healthcare in a research note on Monday, February 4th.

COPYRIGHT VIOLATION WARNING: “Genesis Healthcare Inc (GEN) COO Sells $13,848.00 in Stock” was originally posted by Baseball Daily News and is the property of of Baseball Daily News. If you are viewing this report on another domain, it was stolen and republished in violation of US & international copyright and trademark laws. The correct version of this report can be accessed at https://www.baseballdailydigest.com/news/2019/05/23/genesis-healthcare-inc-gen-coo-sells-13848-00-in-stock.html.

Genesis Healthcare Company Profile

Genesis Healthcare, Inc, together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy.

Further Reading: Momentum Indicator: Relative Strength Index

Insider Buying and Selling by Quarter for Genesis Healthcare (NYSE:GEN)

Receive News & Ratings for Genesis Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.